TriNetX partners with UC Health to offer more access to clinical trials

TriNetX, a health research network, has partnered with UC Health, the University of Cincinnati's health system, to expand its network to offer information on clinical trials to larger audience of patients.

UC Health’s clinical data will be accessible to biopharmaceutical researchers through the expanding network for TriNetX’s 57 million patients. Using the network of millions of patients from around the world gives UC the opportunity to conduct multiple clinical trials in its academic health system, help researchers search for patients eligible for their clinical trials and collaborate with other teams of researchers.  

Through the TriNetX system, users can pick out patients using filters based on many different data points and criteria, and the data points can be tracked the healthcare organization the patient is a part of to see if they would like to participant in a clinical trial.

"UC Health is committed to providing the highest level of advanced specialty care and cutting edge treatment options to our patients and community.  As the region's only academic health system, our researchers focus on clinical trials which can provide many patients the best possible options for their care.  The academic difference is what sets us apart," said Christopher Lindsell, PhD, vice president for research at UC Health and associate dean for clinical research at the University of Cincinnati College of Medicine. "This collaboration provides additional possibilities to improve the health of our patients while leading the practice of medicine to provide superlative top-tier treatments to our community and beyond.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”